Reduced kidney function is a risk factor for atrial fibrillation

There is limited knowledge on the relationship between kidney function and incidence of atrial fibrillation. Thus, this prospective study was designed to evaluate whether various biomarkers of kidney function are associated to the risk of atrial fibrillation. The study population consisted of 1840 s...

Full description

Saved in:
Bibliographic Details
Published inNephrology (Carlton, Vic.) Vol. 21; no. 8; pp. 717 - 720
Main Authors Laukkanen, Jari A, Zaccardi, Francesco, Karppi, Jouni, Ronkainen, Kimmo, Kurl, Sudhir
Format Journal Article
LanguageEnglish
Published Australia Blackwell Publishing Ltd 01.08.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1320-5358
1440-1797
DOI10.1111/nep.12727

Cover

Abstract There is limited knowledge on the relationship between kidney function and incidence of atrial fibrillation. Thus, this prospective study was designed to evaluate whether various biomarkers of kidney function are associated to the risk of atrial fibrillation. The study population consisted of 1840 subjects (615 women and 1225 men) aged 61–82 years. Cystatin C‐ and creatinine‐based estimation of glomerular filtration rate (eGFRcys and eGRFcreat, respectively) and urinary albumin/creatinine ratio (ACR) were assessed to investigate their relationship with the risk of atrial fibrillation. During a median follow‐up of 3.7 years, a total of 159 incident atrial fibrillation cases occurred. After adjustment for potential confounders, the risk of atrial fibrillation was increased (hazard ratio 2.74, 95% confidence interval (CI) 1.56–4.81, P < 0.001) in subjects with reduced kidney function (eGFRcys, 15–59 mL/min per 1.73 m2) compared to subjects with normal kidney function (≥90 mL/min per 1.73 m2). Similar results were also found when comparing the respective groups of subjects defined by their eGRFcreat levels (hazard ratio 2.41, CI 1.09–5.30, P = 0.029). Consistently, subjects with ACR ≥300 mg/g had an increased risk of incident atrial fibrillation (hazard ratio 2.16, CI 1.35–2.82, P < 0.001) compared to those with ACR <30 mg/g. Reduced eGFR and albuminuria were associated with an increased risk of atrial fibrillation.
AbstractList There is limited knowledge on the relationship between kidney function and incidence of atrial fibrillation. Thus, this prospective study was designed to evaluate whether various biomarkers of kidney function are associated to the risk of atrial fibrillation. The study population consisted of 1840 subjects (615 women and 1225 men) aged 61–82 years. Cystatin C‐ and creatinine‐based estimation of glomerular filtration rate (eGFRcys and eGRFcreat, respectively) and urinary albumin/creatinine ratio (ACR) were assessed to investigate their relationship with the risk of atrial fibrillation. During a median follow‐up of 3.7 years, a total of 159 incident atrial fibrillation cases occurred. After adjustment for potential confounders, the risk of atrial fibrillation was increased (hazard ratio 2.74, 95% confidence interval (CI) 1.56–4.81, P < 0.001) in subjects with reduced kidney function (eGFRcys, 15–59 mL/min per 1.73 m2) compared to subjects with normal kidney function (≥90 mL/min per 1.73 m2). Similar results were also found when comparing the respective groups of subjects defined by their eGRFcreat levels (hazard ratio 2.41, CI 1.09–5.30, P = 0.029). Consistently, subjects with ACR ≥300 mg/g had an increased risk of incident atrial fibrillation (hazard ratio 2.16, CI 1.35–2.82, P < 0.001) compared to those with ACR <30 mg/g. Reduced eGFR and albuminuria were associated with an increased risk of atrial fibrillation.
There is limited knowledge on the relationship between kidney function and incidence of atrial fibrillation. Thus, this prospective study was designed to evaluate whether various biomarkers of kidney function are associated to the risk of atrial fibrillation. The study population consisted of 1840 subjects (615 women and 1225 men) aged 61–82 years. Cystatin C‐ and creatinine‐based estimation of glomerular filtration rate (eGFR cys and eGRF creat , respectively) and urinary albumin/creatinine ratio (ACR) were assessed to investigate their relationship with the risk of atrial fibrillation. During a median follow‐up of 3.7 years, a total of 159 incident atrial fibrillation cases occurred. After adjustment for potential confounders, the risk of atrial fibrillation was increased (hazard ratio 2.74, 95% confidence interval (CI) 1.56–4.81, P  < 0.001) in subjects with reduced kidney function (eGFR cys , 15–59 mL/min per 1.73 m 2 ) compared to subjects with normal kidney function (≥90 mL/min per 1.73 m 2 ). Similar results were also found when comparing the respective groups of subjects defined by their eGRF creat levels (hazard ratio 2.41, CI 1.09–5.30, P  = 0.029). Consistently, subjects with ACR ≥300 mg/g had an increased risk of incident atrial fibrillation (hazard ratio 2.16, CI 1.35–2.82, P  < 0.001) compared to those with ACR <30 mg/g. Reduced eGFR and albuminuria were associated with an increased risk of atrial fibrillation.
There is limited knowledge on the relationship between kidney function and incidence of atrial fibrillation. Thus, this prospective study was designed to evaluate whether various biomarkers of kidney function are associated to the risk of atrial fibrillation. The study population consisted of 1840 subjects (615 women and 1225 men) aged 61-82 years. Cystatin C- and creatinine-based estimation of glomerular filtration rate (eGFRcys and eGRFcreat , respectively) and urinary albumin/creatinine ratio (ACR) were assessed to investigate their relationship with the risk of atrial fibrillation. During a median follow-up of 3.7 years, a total of 159 incident atrial fibrillation cases occurred. After adjustment for potential confounders, the risk of atrial fibrillation was increased (hazard ratio 2.74, 95% confidence interval (CI) 1.56-4.81, P < 0.001) in subjects with reduced kidney function (eGFRcys , 15-59 mL/min per 1.73 m(2) ) compared to subjects with normal kidney function (≥90 mL/min per 1.73 m(2) ). Similar results were also found when comparing the respective groups of subjects defined by their eGRFcreat levels (hazard ratio 2.41, CI 1.09-5.30, P = 0.029). Consistently, subjects with ACR ≥300 mg/g had an increased risk of incident atrial fibrillation (hazard ratio 2.16, CI 1.35-2.82, P < 0.001) compared to those with ACR <30 mg/g. Reduced eGFR and albuminuria were associated with an increased risk of atrial fibrillation.
There is limited knowledge on the relationship between kidney function and incidence of atrial fibrillation. Thus, this prospective study was designed to evaluate whether various biomarkers of kidney function are associated to the risk of atrial fibrillation. The study population consisted of 1840 subjects (615 women and 1225 men) aged 61-82years. Cystatin C- and creatinine-based estimation of glomerular filtration rate (eGFR sub(cys) and eGRF sub(creat), respectively) and urinary albumin/creatinine ratio (ACR) were assessed to investigate their relationship with the risk of atrial fibrillation. During a median follow-up of 3.7years, a total of 159 incident atrial fibrillation cases occurred. After adjustment for potential confounders, the risk of atrial fibrillation was increased (hazard ratio 2.74, 95% confidence interval (CI) 1.56-4.81, P<0.001) in subjects with reduced kidney function (eGFR sub(cys), 15-59mL/min per 1.73m super(2)) compared to subjects with normal kidney function ( greater than or equal to 90mL/min per 1.73m super(2)). Similar results were also found when comparing the respective groups of subjects defined by their eGRF sub(creat) levels (hazard ratio 2.41, CI 1.09-5.30, P=0.029). Consistently, subjects with ACR greater than or equal to 300mg/g had an increased risk of incident atrial fibrillation (hazard ratio 2.16, CI 1.35-2.82, P<0.001) compared to those with ACR <30mg/g. Reduced eGFR and albuminuria were associated with an increased risk of atrial fibrillation.
Author Ronkainen, Kimmo
Karppi, Jouni
Laukkanen, Jari A
Zaccardi, Francesco
Kurl, Sudhir
Author_xml – sequence: 1
  givenname: Jari A
  surname: Laukkanen
  fullname: Laukkanen, Jari A
  email: jariantero.laukkanen@uef.fi
  organization: Department of Medicine, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
– sequence: 2
  givenname: Francesco
  surname: Zaccardi
  fullname: Zaccardi, Francesco
  organization: Internal Medicine and Diabetes Care Unit, Catholic University, Rome, Italy
– sequence: 3
  givenname: Jouni
  surname: Karppi
  fullname: Karppi, Jouni
  organization: Department of Medicine, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
– sequence: 4
  givenname: Kimmo
  surname: Ronkainen
  fullname: Ronkainen, Kimmo
  organization: Department of Medicine, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
– sequence: 5
  givenname: Sudhir
  surname: Kurl
  fullname: Kurl, Sudhir
  organization: Department of Medicine, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26780558$$D View this record in MEDLINE/PubMed
BookMark eNqN0c9LHDEUB_BQLP4-9B8oA17qYTRvJsnL3CyiriLbWiw9hkwmgbizM2syg-5_b9ZVD0LFQEgOn-8jeW-HbHR9Zwn5BvQI0jru7OIICizwC9kGxmgOWOFGupcFzXnJ5RbZifGOUsBCwCbZKgRKyrncJid_bDMa22Qz33R2mbmxM4Pvu8zHTGfBx1nmtBn6kLm09RC8bjPn6-DbVq_gHvnqdBvt_su5S_6en92eTvLrXxeXpz-vc8MKhnnDSmlAM9kIRzXXwCTWiByN5awWrqkBoUJHixosc6ZJkoKpqYFqRctd8mNddxH6-9HGQc19NDa9orP9GBVIKgWrSio-QwVFRCgTPXhH7_oxdOkjqqCsQlFxiUl9f1FjPbeNWgQ_12GpXtuYwOEamNDHGKx7I0DVakQqjUg9jyjZ43fW-OG5lUPQvv0o8eBbu_x_aTU9-_2ayNcJHwf7-JbQYaYElsjVv-mFmk5wcnVzBeq2fAKAJ66e
CitedBy_id crossref_primary_10_1093_cvr_cvaa258
crossref_primary_10_3389_fcvm_2023_1060030
crossref_primary_10_1093_ckj_sfae137
crossref_primary_10_3389_fnut_2021_702085
crossref_primary_10_3389_fendo_2023_1277984
crossref_primary_10_1186_s12872_024_04236_9
crossref_primary_10_3389_fcvm_2022_911845
crossref_primary_10_1161_JAHA_122_028496
crossref_primary_10_1161_JAHA_117_005685
crossref_primary_10_1212_WNL_0000000000005606
crossref_primary_10_2215_CJN_01860217
crossref_primary_10_1016_j_ijcard_2020_08_003
Cites_doi 10.1056/NEJMoa1114248
10.1016/j.amjcard.2009.07.026
10.1161/01.CIR.0000042700.48769.59
10.1001/jama.285.18.2370
10.1016/j.cardfail.2009.07.002
10.1111/j.1540-8167.2010.01774.x
10.1161/hc4901.101760
10.1161/01.CIR.0000103131.70301.4F
10.1161/CIRCULATIONAHA.111.020982
10.1053/j.ajkd.2003.10.037
10.1016/S0140-6736(11)60178-5
10.1007/s10654-012-9753-z
10.1016/j.hrthm.2015.03.024
10.1016/j.ahj.2005.03.055
ContentType Journal Article
Copyright 2016 Asian Pacific Society of Nephrology
2016 Asian Pacific Society of Nephrology.
Copyright_xml – notice: 2016 Asian Pacific Society of Nephrology
– notice: 2016 Asian Pacific Society of Nephrology.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
7X8
DOI 10.1111/nep.12727
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE - Academic
Calcium & Calcified Tissue Abstracts
MEDLINE
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1440-1797
EndPage 720
ExternalDocumentID 26780558
10_1111_nep_12727
NEP12727
ark_67375_WNG_NH7HJQJ1_T
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
29M
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
KMS
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XVB
YFH
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AAYCA
ACRPL
ACUHS
ACYXJ
ADNMO
AEFGJ
AFWVQ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
ALVPJ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
7X8
ID FETCH-LOGICAL-c4247-d438c1a48d6f0a5a1487b7757ce54b6fdb17197f02b1e4fcd48d01cb0c19487b3
IEDL.DBID DR2
ISSN 1320-5358
IngestDate Fri Jul 11 08:14:33 EDT 2025
Fri Jul 11 03:24:32 EDT 2025
Fri Jul 25 09:53:48 EDT 2025
Thu Apr 03 07:11:18 EDT 2025
Tue Jul 01 01:01:02 EDT 2025
Thu Apr 24 23:12:28 EDT 2025
Tue Sep 09 05:08:46 EDT 2025
Wed Oct 30 09:51:53 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords cystatin C
atrial fibrillation
albumin/creatinine ratio
glomerular filtration rate
prospective study
Language English
License 2016 Asian Pacific Society of Nephrology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4247-d438c1a48d6f0a5a1487b7757ce54b6fdb17197f02b1e4fcd48d01cb0c19487b3
Notes istex:3E220991DF3C6C2A72A0DBF78D62613CAF7474C0
Supporting info item
ArticleID:NEP12727
ark:/67375/WNG-NH7HJQJ1-T
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 26780558
PQID 2049769587
PQPubID 2045121
PageCount 4
ParticipantIDs proquest_miscellaneous_1808649306
proquest_miscellaneous_1806077713
proquest_journals_2049769587
pubmed_primary_26780558
crossref_primary_10_1111_nep_12727
crossref_citationtrail_10_1111_nep_12727
wiley_primary_10_1111_nep_12727_NEP12727
istex_primary_ark_67375_WNG_NH7HJQJ1_T
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-08
August 2016
2016-08-00
2016-Aug
20160801
PublicationDateYYYYMMDD 2016-08-01
PublicationDate_xml – month: 08
  year: 2016
  text: 2016-08
PublicationDecade 2010
PublicationPlace Australia
PublicationPlace_xml – name: Australia
– name: Richmond
PublicationTitle Nephrology (Carlton, Vic.)
PublicationTitleAlternate Nephrology
PublicationYear 2016
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Aviles RJ, Martin DO, Apperson-Hansen C et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-10.
Shlipak MG, Fried LF, Crump C et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92.
Karppi J, Kurl S, Mäkikallio TH, Ronkainen K, Laukkanen JA. Low levels of plasma carotenoids are associated with an increased risk of atrial fibrillation. Eur. J. Epidemiol. 2013; 28: 45-53.
Alonso A, Lopez FL, Matsushita K, Coresh J. Chronic kidney disease is associated with the incidence of atrial fibrillation: The atherosclerosis risk in communities (ARIC) study. Circulation 2011; 123: 2946-53.
Landray MJ, Wheeler DC, Lip GY et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am. J. Kidney Dis. 2004; 43: 244-53.
Inker LA, Schmid CH, Tighiouart H et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med. 2012; 367: 20-9.
Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379: 165-180.
Patel P, Dokainish H, Tsai P, Lakkis N. Update on the association of inflammation and atrial fibrillation. J. Cardiovasc. Electrophysiol. 2010; 21: 1064-70.
Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ. Kidney function and anemia as risk factors for coronary heart disease and mortality: The atherosclerosis risk in communities (ARIC) study. Am. Heart J. 2006; 151: 492-500.
Deo R, Katz R, Kestenbaum B et al. Impaired kidney function and atrial fibrillation in elderly subjects. J. Card. Fail. 2010; 16: 55-60.
McManus DD, Corteville DC, Shlipak MG, Whooley MA, Ix JH. Relation of kidney function and albuminuria with atrial fibrillation (from the heart and soul study). Am. J. Cardiol. 2009; 104: 1551-5.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39: S1-266.
Khan H, Kella D, Rauramaa R, Savonen K, Lloyd MS, Laukkanen JA. Cardiorespiratory fitness and atrial fibrillation: A population-based follow-up study. Heart Rhythm 2015; 12: 1424-30.
Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001; 285: 2370-5.
Chung MK, Martin DO, Sprecher D et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2010; 104: 2886-91.
2004; 43
2002; 39
2015; 12
2010; 21
2010; 16
2003; 108
2003; 107
2001; 285
2013; 28
2010; 104
2006; 151
2012; 367
2012; 379
2011; 123
2009; 104
National Kidney Foundation (e_1_2_7_4_1) 2002; 39
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
References_xml – reference: Aviles RJ, Martin DO, Apperson-Hansen C et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-10.
– reference: Karppi J, Kurl S, Mäkikallio TH, Ronkainen K, Laukkanen JA. Low levels of plasma carotenoids are associated with an increased risk of atrial fibrillation. Eur. J. Epidemiol. 2013; 28: 45-53.
– reference: McManus DD, Corteville DC, Shlipak MG, Whooley MA, Ix JH. Relation of kidney function and albuminuria with atrial fibrillation (from the heart and soul study). Am. J. Cardiol. 2009; 104: 1551-5.
– reference: Landray MJ, Wheeler DC, Lip GY et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am. J. Kidney Dis. 2004; 43: 244-53.
– reference: Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001; 285: 2370-5.
– reference: Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379: 165-180.
– reference: Inker LA, Schmid CH, Tighiouart H et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med. 2012; 367: 20-9.
– reference: Patel P, Dokainish H, Tsai P, Lakkis N. Update on the association of inflammation and atrial fibrillation. J. Cardiovasc. Electrophysiol. 2010; 21: 1064-70.
– reference: National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39: S1-266.
– reference: Deo R, Katz R, Kestenbaum B et al. Impaired kidney function and atrial fibrillation in elderly subjects. J. Card. Fail. 2010; 16: 55-60.
– reference: Alonso A, Lopez FL, Matsushita K, Coresh J. Chronic kidney disease is associated with the incidence of atrial fibrillation: The atherosclerosis risk in communities (ARIC) study. Circulation 2011; 123: 2946-53.
– reference: Shlipak MG, Fried LF, Crump C et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92.
– reference: Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ. Kidney function and anemia as risk factors for coronary heart disease and mortality: The atherosclerosis risk in communities (ARIC) study. Am. Heart J. 2006; 151: 492-500.
– reference: Chung MK, Martin DO, Sprecher D et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2010; 104: 2886-91.
– reference: Khan H, Kella D, Rauramaa R, Savonen K, Lloyd MS, Laukkanen JA. Cardiorespiratory fitness and atrial fibrillation: A population-based follow-up study. Heart Rhythm 2015; 12: 1424-30.
– volume: 39
  start-page: S1
  year: 2002
  end-page: 266
  article-title: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
  publication-title: Am. J. Kidney Dis.
– volume: 123
  start-page: 2946
  year: 2011
  end-page: 53
  article-title: Chronic kidney disease is associated with the incidence of atrial fibrillation: The atherosclerosis risk in communities (ARIC) study
  publication-title: Circulation
– volume: 104
  start-page: 2886
  year: 2010
  end-page: 91
  article-title: C‐reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation
  publication-title: Circulation
– volume: 104
  start-page: 1551
  year: 2009
  end-page: 5
  article-title: Relation of kidney function and albuminuria with atrial fibrillation (from the heart and soul study)
  publication-title: Am. J. Cardiol.
– volume: 367
  start-page: 20
  year: 2012
  end-page: 9
  article-title: Estimating glomerular filtration rate from serum creatinine and cystatin C
  publication-title: N. Engl. J. Med.
– volume: 285
  start-page: 2370
  year: 2001
  end-page: 5
  article-title: Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study
  publication-title: JAMA
– volume: 12
  start-page: 1424
  year: 2015
  end-page: 30
  article-title: Cardiorespiratory fitness and atrial fibrillation: A population‐based follow‐up study
  publication-title: Heart Rhythm
– volume: 16
  start-page: 55
  year: 2010
  end-page: 60
  article-title: Impaired kidney function and atrial fibrillation in elderly subjects
  publication-title: J. Card. Fail.
– volume: 151
  start-page: 492
  year: 2006
  end-page: 500
  article-title: Kidney function and anemia as risk factors for coronary heart disease and mortality: The atherosclerosis risk in communities (ARIC) study
  publication-title: Am. Heart J.
– volume: 43
  start-page: 244
  year: 2004
  end-page: 53
  article-title: Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study
  publication-title: Am. J. Kidney Dis.
– volume: 107
  start-page: 87
  year: 2003
  end-page: 92
  article-title: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency
  publication-title: Circulation
– volume: 21
  start-page: 1064
  year: 2010
  end-page: 70
  article-title: Update on the association of inflammation and atrial fibrillation
  publication-title: J. Cardiovasc. Electrophysiol.
– volume: 28
  start-page: 45
  year: 2013
  end-page: 53
  article-title: Low levels of plasma carotenoids are associated with an increased risk of atrial fibrillation
  publication-title: Eur. J. Epidemiol.
– volume: 108
  start-page: 3006
  year: 2003
  end-page: 10
  article-title: Inflammation as a risk factor for atrial fibrillation
  publication-title: Circulation
– volume: 379
  start-page: 165
  year: 2012
  end-page: 180
  article-title: Chronic kidney disease
  publication-title: Lancet
– ident: e_1_2_7_6_1
  doi: 10.1056/NEJMoa1114248
– ident: e_1_2_7_11_1
  doi: 10.1016/j.amjcard.2009.07.026
– ident: e_1_2_7_16_1
  doi: 10.1161/01.CIR.0000042700.48769.59
– ident: e_1_2_7_2_1
  doi: 10.1001/jama.285.18.2370
– volume: 39
  start-page: S1
  year: 2002
  ident: e_1_2_7_4_1
  article-title: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
  publication-title: Am. J. Kidney Dis.
– ident: e_1_2_7_9_1
  doi: 10.1016/j.cardfail.2009.07.002
– ident: e_1_2_7_12_1
  doi: 10.1111/j.1540-8167.2010.01774.x
– ident: e_1_2_7_13_1
  doi: 10.1161/hc4901.101760
– ident: e_1_2_7_14_1
  doi: 10.1161/01.CIR.0000103131.70301.4F
– ident: e_1_2_7_10_1
  doi: 10.1161/CIRCULATIONAHA.111.020982
– ident: e_1_2_7_15_1
  doi: 10.1053/j.ajkd.2003.10.037
– ident: e_1_2_7_5_1
  doi: 10.1016/S0140-6736(11)60178-5
– ident: e_1_2_7_7_1
  doi: 10.1007/s10654-012-9753-z
– ident: e_1_2_7_8_1
  doi: 10.1016/j.hrthm.2015.03.024
– ident: e_1_2_7_3_1
  doi: 10.1016/j.ahj.2005.03.055
SSID ssj0017261
Score 2.1728978
Snippet There is limited knowledge on the relationship between kidney function and incidence of atrial fibrillation. Thus, this prospective study was designed to...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 717
SubjectTerms Aged
Aged, 80 and over
albumin/creatinine ratio
Albuminuria - etiology
Albuminuria - physiopathology
atrial fibrillation
Atrial Fibrillation - diagnosis
Atrial Fibrillation - epidemiology
Atrial Fibrillation - physiopathology
Biomarkers - blood
Cardiac arrhythmia
Creatinine
Creatinine - blood
Cystatin C
Cystatin C - blood
Electrocardiography
Epidermal growth factor receptors
Female
Fibrillation
Finland - epidemiology
Glomerular Filtration Rate
Humans
Incidence
Kidney - physiopathology
Kidney Diseases - blood
Kidney Diseases - diagnosis
Kidney Diseases - epidemiology
Kidney Diseases - physiopathology
Kidneys
Male
Middle Aged
Population studies
Predictive Value of Tests
Prospective Studies
prospective study
Risk Factors
Time Factors
Title Reduced kidney function is a risk factor for atrial fibrillation
URI https://api.istex.fr/ark:/67375/WNG-NH7HJQJ1-T/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnep.12727
https://www.ncbi.nlm.nih.gov/pubmed/26780558
https://www.proquest.com/docview/2049769587
https://www.proquest.com/docview/1806077713
https://www.proquest.com/docview/1808649306
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZaxRBEC5ChOCLR7xWY2hFxJdZpmf6GnxRzLEsZNGQYB6Epk8IGyYhuwvqr7drLowkIfg2MDVDdx1dVd3VXwG8iyZyXzqexdxVGTPWZiYKmomKJecnpbcGN_QPZmJyzKYn_GQNPvZ3YVp8iGHDDS2jWa_RwI1d_GXkdbgY0yK537T-0lIgbv7O4QAdlfyyoP0NYV5y1aEKYRXP8OUVX3QP2frzukDzatzaOJ69h_CjH3JbbzIfr5Z27H7_g-b4n3N6BA-6gJR8bjXoMayFehM2Droj9yfw6RDBXYMn81Nfh18EHSEKk5wuiCFYmU7anj0khb_ENF1ASMSLBGdtmd1TON7bPfoyybq2C5ljBZOZZ6Vy1DDlRcwNNylhklZKLl3gzIroLZW0kjEvLA0sOp8oc-ps7miFpOUzWK_P6_ACSMGcSAkdU9R4Zh21zEkjFQ-uKkOIfAQfegFo12GSY2uMM93nJokjuuHICN4OpBctEMd1RO8bKQ4U5nKOlWuS6--zfT2byMn025TqoxFs9WLWndEudJGjflZcpf-8GV4nc8MzFFOH89VCU5WLXMqU2t9KowSrUjI2guetCg0DKgQ2keAqzbxRhJvnome7X5uHl3cnfQX3U0An2gLFLVhfXq7C6xQ0Le12Yx1_AJUlEMs
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9RAEB9qC-oX34_TqquI-CVHNtlXoB8q2hrPXtByxX6RZZ9QrqSldwfav767eWGlivgtkEnI7sxkfrM7-xuA1155anNDE5-aIiFK60R5hhNWkBD8OLdaxQX9acXKAzI5pIdrsNWfhWn5IYYFt-gZzf86OnhckP7Fy2t3OsZZiL_XYIMEoBFTrw_7A3lUiMwM92eEaU5FxysU63iGRy9Fo404sT-ugpqXkWsTenZvw_f-o9uKk_l4tdRjc_4bn-P_juoO3OowKXrXGtFdWHP1Pbg-7Xbd78P2fuR3dRbNj2ztfqIYC6M-0dECKRSL01HbtgcFBIxU0wgE-XiW4LittHsAB7s7s_dl0nVeSAzJCE8syYXBigjLfKqoCjkT15xTbhwlmnmrMccF92mmsSPe2CCZYqNTg4somj-E9fqkdo8BZcSwkNMRgZUl2mBNDFdcUGeK3DlPR_C214A0HS157I5xLPv0JMyIbGZkBK8G0dOWi-MqoTeNGgcJdTaPxWucym_VR1mVvJx8nWA5G8Fmr2fZ-e1CZmk00YKK8J6Xw-3gcXEbRdXuZLWQWKQs5Txk93-VEYwUIR8bwaPWhoYPyljsI0FFGHljCX8ei6x2vjQXT_5d9AXcKGfTPbn3qfr8FG4GfMfaesVNWF-erdyzgKGW-nnjKheiOxTq
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9qC8WXWj972uoqIr7kyCb7FfrSoj3P04ZaWuyDsOwnlCvp0bsD9a_vbr6wUkV8C2QSsjszmd_szv4G4LVXntrc0MSnpkiI0jpRnuGEFSQEP86tVnFB_7Bk41MyOaNnK7DbnYVp-CH6BbfoGfX_Ojr4zPpfnLxysyHOQvi9A2uEBSQREdFxzx0VAjPD3RFhmlPR0grFMp7-0RvBaC3O6_fbkOZN4FpHntE9-NZ9c1NwMh0uF3pofv5G5_ifg9qEjRaRov3GhO7DiqsewPphu-f-EPaOI7urs2h6biv3A8VIGLWJzudIoViajpqmPSjgX6TqNiDIx5MEF02d3SM4HR2cvBsnbd-FxJCM8MSSXBisiLDMp4qqkDFxzTnlxlGimbcac1xwn2YaO-KNDZIpNjo1uIii-WNYrS4rtwUoI4aFjI4IrCzRBmtiuOKCOlPkznk6gLedAqRpScljb4wL2SUnYUZkPSMDeNWLzhomjtuE3tRa7CXU1TSWrnEqv5YfZDnm48mXCZYnA9ju1Cxbr53LLI0GWlAR3vOyvx38LW6iqMpdLucSi5SlnIfc_q8ygpEiZGMDeNKYUP9BGYtdJKgII68N4c9jkeXBUX3x9N9FX8D60fuR_Pyx_PQM7gZwx5pixW1YXVwt3U4AUAv9vHaUa1KbE5k
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduced+kidney+function+is+a+risk+factor+for+atrial+fibrillation&rft.jtitle=Nephrology+%28Carlton%2C+Vic.%29&rft.au=Laukkanen%2C+Jari+A&rft.au=Zaccardi%2C+Francesco&rft.au=Karppi%2C+Jouni&rft.au=Ronkainen%2C+Kimmo&rft.date=2016-08-01&rft.issn=1320-5358&rft.eissn=1440-1797&rft.volume=21&rft.issue=8&rft.spage=717&rft.epage=720&rft_id=info:doi/10.1111%2Fnep.12727&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_nep_12727
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1320-5358&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1320-5358&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1320-5358&client=summon